Immunodiagnostic Systems, the Newcastle based niche Diagnostics Company, has appointed Mr Roland Sackers as Non-Executive Director and Chair of the Audit Committee. Mr Sackers is Chief Financial Officer and a Managing Director at QIAGEN N.V.

QIAGEN are a world leader in sample and assay technologies that enable access to valuable molecular information from any biological sample. The company has sales of over $1 billion and more than 3,500 employees.

Between 2005 and 2007 Mr Sackers headed the expansion of QIAGEN’s business in North America which now accounts for around 50% of group sales. His experience in diagnostics and his reputation amongst international investors are anticipated to benefit IDS.

Unlock the rest of this article with a 14 day trial

or Unlock with your email

Already have an account?
Login here